Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Veracyte
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Veracyte
-
Dr. Clifford Hudis,
@ASCO CEO, speaking with@BonnieAndDx re: challenges for#PrecisionMedicine in the next decade: “The big issue will be access and affordability. And proving that some of these [new] therapies are demonstrably better and defining what ‘better’ means.”#PMWC20pic.twitter.com/W6XJY63z4q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Clifford Hudis on
@ASCO’s#CancerLinQ big data initiative: “Our data looks exactly like America. It’s not pristine data because it includes everything. It gives us a broader view into the real world.”#PMWC20@PMWCintlHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Clifford Hudis, CEO of
@ASCO, in fireside chat with@BonnieAndDx at#PMWC20: “When you look across the spectrum of healthcare, I defy you to find a consistent definition of quality. ... The easy thing to measure is process. That doesn’t equate to outcomes.”@PMWCintlpic.twitter.com/ul3bgZacil
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join our CEO, Bonnie Anderson, and Dr. Clifford Hudis, CEO of
@ASCO tomorrow at#PMWC20 for a fireside chat about the future of data-driven cancer care. Fri., Jan. 24, 9 a.m., Track 3.#PrecisionMedicine@PMWCintlpic.twitter.com/IrNw68fGdp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Veracyte, Inc. proslijedio/la je Tweet
What an honor it is to introduce Brook Byers tonight as the winner of the
#PMWC20 Pioneer Award. Brook was a founding funder of Veracyte and so many other companies that today are making#PrecisionMedicine a reality for patients.@PMWCintlpic.twitter.com/hZxYsyRe5O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Data science is increasingly changing how physicians diagnose, manage and treat cancer patients. Want to know what’s happening and what’s next? Tune in to Bonnie Anderson’s fireside chat with Dr. Clifford Hudis, CEO of
@ASCO, at#PMWC2020 on Friday, Jan. 24, 9 a.m. (Track 3).pic.twitter.com/grDa5biTKp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@BonnieAndDx on Veracyte’s sponsorship of the 2019 Mt. Kilimanjaro@climbtofight: "We aligned on a series of initiatives to make all employees a part of the journey." Result? >$100K in Veracyte donations, with 75% of employees participating.@fredhutchpic.twitter.com/DYdaFgDjrV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@ldtimmerman, at#biotechshowcase2020 panel, on how he got started rallying the#biotech community to climb mountains and raise $ for cancer research: “I try to make the world better in my journalism. But, I thought, there’s got to be more.”@climbtofight@fredhutchpic.twitter.com/IQRmML3TNB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Veracyte, Inc. proslijedio/la je Tweet
Great to kick off
#JPM20 at the@Nasdaq opening bell ringing this morning with Keith Kennedy, Veracyte’s awesome CFO/COO!pic.twitter.com/kDCGUVBi5P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re excited to announce a biopharmaceutical collaboration with Acerta Pharma and AstraZeneca — which is enabled by our expanding global footprint and
#genomic tests in new oncology indications. https://investor.veracyte.com/news-releases/news-release-details/veracyte-announces-biopharmaceutical-collaboration-acerta-pharma …#PrecisionMedicineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to Dr. Jonathan Chung, recipient of an
@accpchest 2019 Alfred Soffer Research Award for his role in research demonstrating that our#Envisia Genomic Classifier combined w/HRCT supports a more confident#IPF diagnosis!@jonherochunghttp://bit.ly/EnvisiaCHEST19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We took time out on Friday to celebrate our major step towards expanding our business internationally. https://investor.veracyte.com/news-releases/news-release-details/veracyte-acquires-exclusive-license-nanostring-diagnostics …pic.twitter.com/SuwiVtC65f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Veracyte, Inc. proslijedio/la je Tweet
Veracyte is paying $50M for global rights to develop and commercialize diagnostic tests on NanoString's flagship gene analysis tech. Deal is combination of cash & stock...https://xconomy.com/san-francisco/2019/12/03/veracyte-aims-to-expand-diagnostics-reach-with-50m-nanostring-deal/ …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce a strategic transaction that will enable us to bring our advanced genomic tests to physicians and their patients around the world!
#PrecisionMedicinehttps://investor.veracyte.com/news-releases/news-release-details/veracyte-acquires-exclusive-license-nanostring-diagnostics …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Together with
@JNJInnovation, Veracyte is developing the first noninvasive nasal swab classifier for early detection and diagnosis of#lungcancer. Come hear our CEO Bonnie Anderson share more! https://jlabs.tv/2CBtL44@JLABSpic.twitter.com/u4UFssQeGj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We come to work every day to
#ChangeLungCancer detection and diagnosis for thousands of patients and their families. Thanks to@LUNGevity for the opportunity to share what inspires us during#LCAM.pic.twitter.com/3idxsugTmB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@GO2Foundation suggests several great ways to help the#lungcancer community during#LCAM. Check out their blog below!https://twitter.com/GO2Foundation/status/1192517180920909824 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good news from
@LungAssociation: The#lungcancer survival rate has increased dramatically over the past 10 years. We’re proud to be part of the community that is working to save more lives through earlier disease detection and diagnosis.#LCAMhttps://www.lung.org/local-content/_content-items/about-us/media/press-releases/state-of-lung-cancer-2019-3.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Veracyte, Inc. proslijedio/la je Tweet
Kudos
@Veracyte for developing a genomic classifier into clinical practice - it’s really hard & you did that!#PFFSummit2019https://twitter.com/Juani1000/status/1192877785213218816 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are honored that Dr. Sangeeta Bhorade, our medical director of pulmonology, had the opportunity to share an overview of our
#Envisia Genomic Classifier @#PFFSummit2019 today. The genomic test has now been used at >135 US hospitals to help improve#IPF diagnosis.pic.twitter.com/xgPw2SQjES
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.